Sirera R - Search Results

1

Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).

Iranzo V, Sirera R, Carrato A, Cabrera A, Jantus E, Guijarro R, Sanmartín E, Blasco A, Gil M, Gómez-Aldaraví L, González-Larriba JL, Massuti B, Velasco A, Provencio M, Rossell R, Camps C. Iranzo V, et al. Among authors: sirera r. Clin Transl Oncol. 2011 Jun;13(6):411-8. doi: 10.1007/s12094-011-0675-0. Clin Transl Oncol. 2011. PMID: 21680302 Clinical Trial.

2

Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?

Bremnes RM, Sirera R, Camps C. Bremnes RM, et al. Among authors: sirera r. Lung Cancer. 2005 Jul;49(1):1-12. doi: 10.1016/j.lungcan.2004.12.008. Lung Cancer. 2005. PMID: 15949585 Review.

3

Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?

Camps C, Sirera R, Bremnes R, Blasco A, Sancho E, Bayo P, Safont MJ, Sánchez JJ, Tarón M, Rosell R. Camps C, et al. Among authors: sirera r. Lung Cancer. 2005 Dec;50(3):339-46. doi: 10.1016/j.lungcan.2005.06.007. Epub 2005 Sep 1. Lung Cancer. 2005. PMID: 16139926

4

Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.

Camps C, Caballero C, Blasco A, Safont MJ, Berrocal A, Garde J, Juarez A, Sirera R, Bremnes RM. Camps C, et al. Among authors: sirera r. Anticancer Res. 2005 Nov-Dec;25(6C):4611-4. Anticancer Res. 2005. PMID: 16334151 Free article. Clinical Trial.

5

Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.

Bremnes RM, Camps C, Sirera R. Bremnes RM, et al. Among authors: sirera r. Lung Cancer. 2006 Feb;51(2):143-58. doi: 10.1016/j.lungcan.2005.09.005. Epub 2005 Dec 19. Lung Cancer. 2006. PMID: 16360975 Review.

6

Analysis of c-kit expression in small cell lung cancer: prevalence and prognostic implications.

Camps C, Sirera R, Bremnes RM, Garde J, Safont MJ, Blasco A, Berrocal A, Sánchez JJ, Calabuig C, Martorell M. Camps C, et al. Among authors: sirera r. Lung Cancer. 2006 Jun;52(3):343-7. doi: 10.1016/j.lungcan.2006.02.003. Epub 2006 Mar 30. Lung Cancer. 2006. PMID: 16574270

7

Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Camps C, Iranzo V, Bremnes RM, Sirera R. Camps C, et al. Among authors: sirera r. Support Care Cancer. 2006 Dec;14(12):1173-83. doi: 10.1007/s00520-006-0097-7. Epub 2006 Jul 4. Support Care Cancer. 2006. PMID: 16819628 Review.

8

Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.

Camps C, Sirera R, Bremnes RM, Ródenas V, Blasco A, Safont MJ, Garde J, Juarez A, Caballero C, Sanchez JJ, Taron M, Rosell R. Camps C, et al. Among authors: sirera r. Anticancer Res. 2006 Nov-Dec;26(6C):4905-9. Anticancer Res. 2006. PMID: 17214360 Free article.

9

Venous thromboembolic disease in cancer. Optimisation of the use of antithrombotic agents.

Camps C, Juárez A, Iranzo V, Garde J, Blasco A, Sirera R. Camps C, et al. Among authors: sirera r. Clin Transl Oncol. 2007 Mar;9(3):161-71. doi: 10.1007/s12094-007-0030-7. Clin Transl Oncol. 2007. PMID: 17403627 Review.

10

Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.

Camps C, Sirera R, Iranzo V, Tarón M, Rosell R. Camps C, et al. Among authors: sirera r. Clin Lung Cancer. 2007 May;8(6):369-75. doi: 10.3816/CLC.2007.n.017. Clin Lung Cancer. 2007. PMID: 17562237 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters